CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)	Total	Additional Paid-In Capital	Accumulated Deficit	Common Stock Class A [Member]	Common Stock Class B [Member]
Balance, shares at Feb. 28, 2018				1,178,762	567
Balance, amount at Feb. 28, 2018	$ (1,516,000)	$ 27,289,820	$ (28,807,000)	$ 1,179	$ 1
Net income/loss	(148,000)	0	(148,000)	$ 0	$ 0
Balance, shares at Feb. 28, 2019				1,178,762	567
Balance, amount at Feb. 28, 2019	(1,664,000)	27,289,820	(28,955,000)	$ 1,179	$ 1
Net income/loss	(134,000)	0	(134,000)	$ 0	$ 0
Balance, shares at Feb. 29, 2020				1,178,762	567
Balance, amount at Feb. 29, 2020	(1,798,000)	27,289,820	(29,089,000)	$ 1,179	$ 1
Net income/loss	247,276		247,276	0	0
Payment of accounts payable and accrued expenses by Activist Investing LLC on July 2, 2020 pursuant to Stock Purchase Agreement dated June 30, 2020	37,000	37,000	0	$ 0	$ 0
Conversion of notes payable and Accrued interest to Class A shares on September 23, 2020, shares				116,697,438
Conversion of notes payable and Accrued interest to Class A shares on September 23, 2020, amount	1,472,000	1,355,303	0	$ 116,697	$ 0
Payment of accrued expenses ($3,000) and due to related parties ($9,000) by Activist Investing LLC in the three months ended November 30, 2020 pursuant to Stock Purchase Agreement dated June 30, 2020	12,000	12,000	0	0	0
Company expenses paid by Platinum International Biotech Co. Ltd. (Cayman Islands) and affiliates	22,298	22,298	0	$ 0	$ 0
Adjustments, shares				(877)	3,880
Adjustments, amount	0	(2)	0	$ (1)	$ 3
Balance, shares at Dec. 31, 2020				117,875,323	4,447
Balance, amount at Dec. 31, 2020	$ (7,426)	$ 28,716,419	$ (28,841,724)	$ 117,875	$ 4